Kezar Life Sciences, Inc. (KZR)
NASDAQ·Healthcare·Biotechnology
$7.34
—
Mkt Cap $51.26M
Analyst Ratings
No recent rating data.
Price Target (5 analysts)
$11.00
Range $5.00 – $21.00
Implied Upside
+49.9%
Consensus $11.00 vs current $7.34
NASDAQ·Healthcare·Biotechnology
$7.34
—
Mkt Cap $51.26M
No recent rating data.
Price Target (5 analysts)
$11.00
Range $5.00 – $21.00
+49.9%
Consensus $11.00 vs current $7.34